Tower Research Capital LLC (TRC) - ENZO BIOCHEM INC ownership

ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 90 filers reported holding ENZO BIOCHEM INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of ENZO BIOCHEM INC
ValueSharesWeighting
Q3 2023$21,634
+18.7%
15,453
+55.9%
0.00%0.0%
Q2 2023$18,233
+107152.9%
9,909
+45.6%
0.00%0.0%
Q1 2023$17
-54.1%
6,804
-73.9%
0.00%
-50.0%
Q4 2022$37
-99.9%
26,056
+0.9%
0.00%
+100.0%
Q3 2022$57,000
-16.2%
25,832
-21.2%
0.00%
-50.0%
Q2 2022$68,000
-37.0%
32,792
-11.6%
0.00%
+100.0%
Q1 2022$108,000
+22.7%
37,094
+35.7%
0.00%
-50.0%
Q4 2021$88,000
+72.5%
27,326
+83.6%
0.00%
+100.0%
Q1 2021$51,000
-23.9%
14,887
-43.8%
0.00%
-50.0%
Q4 2020$67,000
-50.4%
26,512
-58.6%
0.00%
+100.0%
Q3 2020$135,000
+309.1%
63,980
+328.7%
0.00%0.0%
Q2 2020$33,000
+22.2%
14,924
+44.9%
0.00%
-50.0%
Q4 2019$27,000
+2600.0%
10,301
+6298.1%
0.00%
Q3 2019$1,000
-98.0%
161
-98.9%
0.00%
-100.0%
Q2 2019$50,000
+733.3%
14,820
+558.7%
0.00%
Q1 2019$6,0002,250
+7935.7%
0.00%
Q3 2018$0
-100.0%
28
-97.4%
0.00%
-100.0%
Q1 2018$6,000
-91.9%
1,082
-88.0%
0.00%
-90.0%
Q4 2017$74,000
+117.6%
9,052
+179.1%
0.01%
+233.3%
Q3 2017$34,0003,2430.00%
Q2 2017$0
-100.0%
0
-100.0%
0.00%
-100.0%
Q4 2016$5,000
-28.6%
718
-49.6%
0.00%0.0%
Q3 2016$7,000
+75.0%
1,426
+61.5%
0.00%0.0%
Q1 2016$4,000
-71.4%
883
-79.4%
0.00%0.0%
Q3 2015$14,000
-33.3%
4,288
-37.2%
0.00%
-50.0%
Q2 2015$21,000
+162.5%
6,824
+140.0%
0.00%
+100.0%
Q1 2015$8,000
-84.0%
2,843
-70.6%
0.00%
-83.3%
Q3 2014$50,000
-33.3%
9,680
-32.9%
0.01%
-40.0%
Q2 2014$75,000
+7400.0%
14,416
+3154.2%
0.01%
Q4 2013$1,000443
+397.8%
0.00%
Q3 2013$0890.00%
Other shareholders
ENZO BIOCHEM INC shareholders Q1 2015
NameSharesValueWeighting ↓
Roumell Asset Management, LLC 2,736,719$9,414,00013.61%
HARBERT FUND ADVISORS, INC. 5,175,913$17,805,0008.40%
Evermore Global Advisors, LLC 2,605,607$8,963,0006.32%
KEMPNER CAPITAL MANAGEMENT INC. 95,476$328,0000.19%
CORRADO ADVISORS, LLC 46,816$161,0000.12%
MYDA Advisors LLC 35,000$120,0000.03%
Cutter & CO Brokerage, Inc. 29,827$103,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 258,700$890,0000.02%
Paradigm Financial Partners, LLC 18,000$62,0000.02%
Renaissance Technologies 3,340,864$11,493,0000.01%
View complete list of ENZO BIOCHEM INC shareholders